Evidence map›Paper›PMID 42911451›Full record

ArticleMolecular neurobiology2026

Opposing Patterns of the Histone Variant MacroH2A1.1 in Fmr1 Knockout and BTBR T+ Itpr3tf/J Mouse Models of Autism Spectrum Disorder.

Martin N Ivanov, Andon Mladenov, Desislava K Tsoneva, Alessandro Napoli, Tommaso Mazza, Anton B Tonchev, Irene Coppola, Valentina Chiodi, Anna Maria Tartaglione, Manlio Vinciguerra and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Martin N Ivanov *Department of Anatomy and Cell Biology, Research Institute of the Medical University of Varna, Varna, Bulgaria.
Andon Mladenov *Department of Anatomy and Cell Biology, Research Institute of the Medical University of Varna, Varna, Bulgaria.
Desislava K Tsoneva *Department of Medical Genetics, Medical University of Varna, Varna, Bulgaria.
Alessandro NapoliComputational Biology and Bioinformatics Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Tommaso MazzaComputational Biology and Bioinformatics Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Anton B TonchevDepartment of Anatomy and Cell Biology, Research Institute of the Medical University of Varna, Varna, Bulgaria.
Irene CoppolaNational Centre for Drug Research and Evaluation, Istituto Superiore Di Sanità, Rome, Italy.
Valentina ChiodiNational Centre for Drug Research and Evaluation, Istituto Superiore Di Sanità, Rome, Italy.
Anna Maria TartaglioneCentre for Behavioral Sciences and Mental Health, Istituto Superiore Di Sanità, Rome, Italy.
Manlio VinciguerraDepartment of Stem Cell Biology, Research Institute of the Medical University of Varna, Varna, Bulgaria. manlio.vinciguerra@mu-varna.bg.
Maria Rosaria DomeniciNational Centre for Drug Research and Evaluation, Istituto Superiore Di Sanità, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autism spectrum disorder (ASD) exhibits substantial heterogeneity, wherein genetic and idiopathic forms may converge on shared core phenotypes through divergent molecular pathways. The histone variant macroH2A1.1, implicated in chromatin repression and DNA repair, has been linked to behavioral alterations opposite to core ASD features when depleted systemically. However, its regional and cell-type-specific regulation in genetic versus idiopathic ASD models remains unclear. We investigated macroH2A1.1 expression across the dorsal striatum, hippocampus, and medial prefrontal cortex in Fmr1 knockout (Fragile X syndrome model) and BTBR T+ Itpr3tf/J (idiopathic ASD model) mice. Quantitative PCR and imaging analyses revealed opposing patterns: BTBR mice showed region-specific mRNA downregulation and increased strongly stained macroH2A1.1-positive nuclei, whereas Fmr1 knockout mice exhibited reduced strong staining with increased weak staining, specific to neurons and not astrocytes, independent of significant mRNA changes. Bulk RNA-seq meta-analysis and pseudobulk single-cell transcriptomics further identified pathway-level enrichment of oxidative phosphorylation, chromatin remodeling, and transcriptional repression functional gene sets in unmatched public datasets (BTBR striatum; FXS hippocampus and cortex), with pronounced neuron-astrocyte divergence in Fmr1 knockout cortex. These findings underscore distinct epigenetic regulatory mechanisms in genetic and idiopathic ASD models.

Indexed as

Autism Spectrum DisorderFragile X Messenger Ribonucleoprotein 1HistonesAnimalsDisease Models, AnimalMaleMiceMice, Inbred C57BLMice, KnockoutRNA, MessengerFmr1 protein, mouseFragile X Messenger Ribonucleoprotein 1HistonesmacroH2A histoneRNA, MessengerAutism spectrum disorder (ASD)EpigeneticsHistonesMacroH2A1.1Transcriptomics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.